Omnimmune Holdings (merged with Roughneck) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Omnimmune Holdings (merged with Roughneck) General Information


Developer of cancer therapeutic medicines. The company provides diagnostic and prognostic technologies for cancer treatment.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Primary Office
  • 4550 Post Oak Place Drive
  • Suite 224
  • Houston, TX 77027
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Omnimmune Holdings (merged with Roughneck) Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Omnimmune Holdings (merged with Roughneck)‘s full profile, request access.

Request a free trial

Omnimmune Holdings (merged with Roughneck) Executive Team (2)

Name Title Board Seat Contact Info
Harris Lichtenstein Chief Executive Officer, President, Director & Founder
You’re viewing 1 of 2 executive team members. Get the full list »